Plain-English translation of NCT07288567 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a medication called can help teenagers with schizophrenia manage their symptoms better and more safely than current treatments. About 166 teenagers will participate, and half will receive the medication while the other half receive a placebo (a pill with no active ingredient) to fairly compare how well it works.
Schizophrenia in teenagers is serious and difficult to treat, and current medications don't work well for everyone or can cause uncomfortable side effects. This trial aims to see if this medication offers a better, safer option for young people.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic multiple times over several weeks. At the beginning, doctors would confirm your diagnosis and assess your symptoms using rating scales. You would then randomly receive either or a placebo, and take it as directed while the research team monitors how you respond and checks for any side effects through regular visits and assessments.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States